Bausch + Lomb Corporation (BLCO) Key Metrics

NYSE: BLCOValuation, returns, debt and efficiency ratios over 8 years.

BLCO valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$5.89B
Enterprise value
$10.87B
P/E (TTM)
—
Forward P/E
11.4
PEG ratio
0.89
Price / sales
1.1
10-yr median 1.4
Price / book
1.0
10-yr median 0.9
EV / EBITDA
14.8
10-yr median 19.4
Dividend yield
—
Beta
0.56

BLCO key metrics, 2018–2025

Fiscal year ended December 31, 2025 · U.S. dollars

BLCO valuation Price multiples at each fiscal year-end price.

Price / sales−10.7%
1.2
2025 · hover or tap a bar for each year
2022: 1.42023: 1.4 (+0.1%)2024: 1.3 (−8.1%)2025: 1.2 (−10.7%)
20182025
Price / book−4.5%
0.9
2025 · hover or tap a bar for each year
2022: 0.82023: 0.9 (+13.1%)2024: 1.0 (+12.4%)2025: 0.9 (−4.5%)
20182025
EV / EBITDA+12.8%
20.6
2025 · hover or tap a bar for each year
2022: 12.72023: 20.7 (+62.7%)2024: 18.3 (−11.6%)2025: 20.6 (+12.8%)
20182025
Free cash flow yield−0.2 pts
−1.1%
2025 · hover or tap a bar for each year
2022: 3.1%2023: −3.3% (−6.4 pts)2024: −0.9% (+2.4 pts)2025: −1.1% (−0.2 pts)
20182025

BLCO valuation history

Fiscal year-endToday8-year median

BLCO returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

BLCO debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

BLCO cash returned to shareholders

DividendsBuybacksFree cash flow

BLCO price vs earnings per share

Share price at year-endEPS (right axis)

BLCO key metrics

2018–2025
Bausch + Lomb Corporation key metrics by fiscal year
20252024202320222021202020192018
Valuation
Market capitalization$6.04B$6.35B$5.98B$5.43B————
Enterprise value$11.03B$10.98B$10.32B$7.60B————
P/E ratio———904.8————
Price / sales1.21.31.41.4————
Price / book0.91.00.90.8————
Price / free cash flow———31.9————
Price / operating cash flow21.427.4—15.7————
EV / sales2.22.32.52.0————
EV / EBITDA20.618.320.712.7————
EV / free cash flow———44.7————
Earnings yield−6.0%−5.0%−4.3%0.1%————
Free cash flow yield−1.1%−0.9%−3.3%3.1%————
Shareholder yield (dividends + buybacks)—0.2%0.2%0.2%————
Share price at fiscal year-end$17.08$18.06$17.06$15.51————
Per share
Revenue per share$14.42$13.62$11.83$10.77$10.76$9.75$10.79$10.47
Earnings per share−$1.02−$0.90−$0.74$0.02$0.52−$0.05$0.85$2.03
Operating cash flow per share$0.80$0.66−$0.05$0.99$2.49$1.49$2.28$2.18
Free cash flow per share−$0.19−$0.17−$0.56$0.49$1.94$0.75$1.77$1.89
Cash per share$1.08$0.87$0.95$1.09$0.50$0.68$0.55—
Book value per share$18.22$18.40$19.54$20.09$26.65$28.34$28.45—
Tangible book value per share−$4.50−$4.39−$3.75$1.34$7.08$7.63$7.29—
Capex per share$0.99$0.83$0.52$0.50$0.55$0.74$0.51$0.29
Debt per share$15.18$14.03$13.34$7.30$0.40$0.29$0.27—
Shares outstanding353.8M351.8M350.5M350.0M350.0M350.0M350.0M350.0M
Change in shares outstanding+0.6%+0.4%+0.1%0.0%0.0%0.0%0.0%—
Returns & profitability
Return on equity (ROE)−5.6%−4.8%−3.7%0.1%1.9%−0.2%3.0%—
Return on invested capital (ROIC)1.3%1.1%1.0%1.1%2.1%1.3%3.0%—
Return on assets (ROA)−2.6%−2.4%−2.1%0.1%1.6%−0.2%2.6%—
Return on tangible assets−6.0%−5.8%−4.9%0.1%4.6%−0.4%7.3%—
Free cash flow margin−1.3%−1.2%−4.8%4.5%18.1%7.7%16.4%18.1%
Income quality (OCF / net income)———57.504.80—2.681.07
Financial health
Total debt$5.37B$4.94B$4.68B$2.55B$140.0M$101.0M$93.0M—
Cash & short-term investments$383.0M$305.0M$334.0M$380.0M$174.0M$238.0M$192.0M—
Net debt$4.99B$4.63B$4.34B$2.17B−$34.0M−$137.0M−$99.0M—
Debt / equity0.830.760.680.360.020.010.01—
Debt / assets0.380.370.350.230.010.010.01—
Net debt / EBITDA9.327.718.703.64−0.05−0.19−0.11—
Current ratio1.551.601.741.651.491.821.64—
Quick ratio1.041.011.091.160.971.141.07—
Interest coverage0.40.40.51.45.213.72.952.0
Working capital$1.06B$1.05B$1.16B$841.0M$536.0M$745.0M$660.0M—
Invested capital$11.44B$11.10B$11.19B$9.21B$9.29B$9.78B$9.86B—
Tangible asset value−$1.52B−$1.47B−$1.24B$536.0M$2.55B$2.74B$2.62B—
Net current asset value−$4.53B−$4.14B−$3.78B−$1.91B$214.0M$376.0M$259.0M—
Graham number———$2.78$17.66—$23.35—
Graham net-net per share−$16.16−$15.16−$14.32−$8.01−$1.20−$0.71−$1.18—
Capital allocation
Share buybacks (net)—$12.0M$10.0M$11.0M————
Dividends + buybacks / free cash flow———6.5%————
Capex / revenue6.8%6.1%4.4%4.6%5.1%7.6%4.8%2.8%
Capex / operating cash flow123.3%125.4%—50.7%22.1%49.6%22.5%13.2%
Capex / depreciation0.830.670.470.460.470.590.380.20
Stock-based compensation / revenue2.9%1.9%1.8%1.6%1.6%1.5%1.3%1.2%
R&D / revenue7.3%7.2%7.8%8.1%7.2%8.2%6.8%6.0%
SG&A / revenue43.8%43.5%41.9%39.2%36.9%36.7%36.6%36.2%
Efficiency
Days sales outstanding80.472.470.570.166.272.668.9—
Days of inventory on hand159.1201.2184.1144.2147.8171.6162.8—
Days payables outstanding61.488.893.366.851.962.572.1—
Cash conversion cycle (days)178.0184.8161.3147.5162.1181.7159.7—
Receivables turnover4.545.045.185.215.515.035.30—
Payables turnover5.944.113.915.467.045.845.06—
Inventory turnover2.291.811.982.532.472.132.24—
Asset turnover0.370.360.340.340.340.300.33—
Average receivables$1.12B$950.5M$800.5M$723.5M$683.0M$679.0M$713.0M—
Average payables$388.5M$455.5M$419.5M$278.0M$208.5M$220.0M$262.0M—
Average inventory$1.01B$1.03B$828.0M$600.0M$594.0M$604.0M$592.0M—
Intangibles / total assets57.3%59.5%60.7%58.9%63.3%64.3%64.6%—

Computed from BLCO's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

BLCO valuation and financial ratios

Bausch + Lomb earned a return on equity of −5.6% and a return on invested capital of 1.3% in fiscal 2025. It ended the year with $5.4 billion of debt and $383.0 million in cash and short-term investments, net debt of $5.0 billion.

See the BLCO income statement, the BLCO chart for price history, or the BLCO stock overview for the latest quote and news.

BLCO key metrics FAQ

What is Bausch + Lomb's EV/EBITDA?

Bausch + Lomb's enterprise value was 20.6 times EBITDA at the end of fiscal 2025 (enterprise value $11.0 billion, EBITDA $535.0 million); the current EV/EBITDA is 14.8.

What is Bausch + Lomb's return on equity?

Bausch + Lomb's return on equity (ROE) was −5.6% in fiscal 2025: net income of -$360.0 million on average shareholders' equity of $6.5 billion.

What is Bausch + Lomb's ROIC?

Bausch + Lomb's return on invested capital was 1.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Bausch + Lomb have?

Bausch + Lomb had total debt of $5.4 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.83 and $5.0 billion of net debt (9.32 times EBITDA).

What is Bausch + Lomb's free cash flow yield?

Bausch + Lomb generated -$66.0 million of free cash flow in fiscal 2025, a free cash flow yield of −1.1% on its market value at year-end ($6.0 billion).

What is Bausch + Lomb's current ratio?

Bausch + Lomb's current ratio was 1.55 at the end of fiscal 2025: current assets were 1.55 times current liabilities.

Medical Instruments & Supplies key metrics